07:31 EST Eli Lilly falls $3.16 to $777 after FDA delays decision on Alzheimer’s drug
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LLY:
- Viking Therapeutics initiated with a Buy at Jefferies
- Eli Lilly & Co. (NYSE:LLY) Slips on Soaring Demand News
- Foghorn Therapeutics, Eli Lilly to present new preclinical data at AACR
- Healthcare Stocks Retreat after New Task Force Is Formed
- Eli Lilly works to boost production of weight-loss drug, FT says
